These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 3134901

  • 1. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F.
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [Abstract] [Full Text] [Related]

  • 2. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 3. [New thrombolytic agents].
    Nguyen G, Samama M.
    Ann Biol Clin (Paris); 1987 Nov; 45(2):212-8. PubMed ID: 3113300
    [Abstract] [Full Text] [Related]

  • 4. Fibrin-specific thrombolytic agents.
    Collen D.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1791-8. PubMed ID: 3122317
    [Abstract] [Full Text] [Related]

  • 5. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V, Pannell R.
    Thromb Haemost; 1987 Jun 03; 57(3):372-3. PubMed ID: 3116707
    [No Abstract] [Full Text] [Related]

  • 6. Fibrinolytic agents: mechanisms of activity and pharmacology.
    Lijnen HR, Collen D.
    Thromb Haemost; 1995 Jul 03; 74(1):387-90. PubMed ID: 8578491
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D, Lijnen HR.
    Thromb Haemost; 1995 Jul 03; 74(1):167-71. PubMed ID: 8578451
    [Abstract] [Full Text] [Related]

  • 8. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D.
    Prog Hemost Thromb; 1986 Jul 03; 8():1-18. PubMed ID: 3104986
    [No Abstract] [Full Text] [Related]

  • 9. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET, Mack DL, Sobel BE.
    Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679
    [Abstract] [Full Text] [Related]

  • 10. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M, Melzig MF.
    J Pharm Pharmacol; 2012 Aug 24; 64(8):1025-39. PubMed ID: 22775207
    [Abstract] [Full Text] [Related]

  • 11. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M, Cavallo LG, Agnelli G, Mele A, Bürgi R, Heim J, Semeraro N.
    Thromb Haemost; 1993 May 03; 69(5):466-72. PubMed ID: 8391727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, De Cock F, Collen D.
    Thromb Haemost; 1988 Oct 31; 60(2):247-50. PubMed ID: 3146141
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function.
    Wojta J, Binder BR, Huber K, Hoover RL.
    Thromb Haemost; 1989 Apr 25; 61(2):289-93. PubMed ID: 2501899
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrin-specific thrombolytic agents.
    Collen D.
    Klin Wochenschr; 1988 Apr 25; 66 Suppl 12():15-23. PubMed ID: 3126344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.